Unknown

Dataset Information

0

Immunohistochemical analysis of CD155 expression in triple-negative breast cancer patients.


ABSTRACT:

Introduction

CD155 is an immune checkpoint protein. Its overexpression is an indicator of poor prognosis in some types of cancer. However, the significance of CD155 expression in patients with triple-negative breast cancer, and the relationship between CD155 and programmed death-ligand 1 (PD-L1) expression, have not yet been analyzed in detail.

Methods

Using immunohistochemical staining and tissue microarrays, we analyzed the expression profiles of CD155 and PD-L1 in 61 patients with triple-negative breast cancer. Relapse-free survival and overall survival rates were compared according to CD155 expression. The correlation between CD155 expression and clinicopathological factors, including PD-L1 expression (using SP142 and 73-10 assays), was also examined.

Results

CD155 expression was noted in 25 patients (41.0%) in this cohort. CD155 expression did not correlate with pathological stage, histological grade, Ki-67 labeling index, or stromal tumor-infiltrating lymphocytes. Only PD-L1 expression in tumor cells by SP142 assay significantly correlated with CD155 expression (p = 0.035); however, PD-L1 expression in tumor cells by 73-10 assay did not show a correlation (p = 0.115). Using the 73-10 assay, 59% of patients showed CD155 and/or PD-L1 expression in tumor cells. Moreover, using the SP142 assay, 63.3% of patients showed CD155 and/or PD-L1 expression in immune cells. CD155 expression did not correlate with either relapse-free survival or overall survival (p = 0.485 and 0.843, respectively).

Conclusions

CD155 may be a novel target for antitumor immunotherapy. The results of this study indicate that CD155 may expand the pool of candidates with triple-negative breast cancer who could benefit from antitumor immunotherapy.

SUBMITTER: Yoshikawa K 

PROVIDER: S-EPMC8195407 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC7004517 | biostudies-literature
| S-EPMC7383258 | biostudies-literature
| S-EPMC6420381 | biostudies-literature
| S-EPMC7810824 | biostudies-literature
| S-EPMC10809386 | biostudies-literature
| S-EPMC4763414 | biostudies-literature
| S-EPMC7918547 | biostudies-literature
| S-EPMC4000553 | biostudies-literature
| S-EPMC6817452 | biostudies-literature
| S-EPMC8033085 | biostudies-literature